Clover Health Investments, Corp. (CLOV)
| Market Cap | 912.98M -50.9% |
| Revenue (ttm) | 1.92B +40.3% |
| Net Income | -85.55M |
| EPS | -0.17 |
| Shares Out | 485.63M |
| PE Ratio | n/a |
| Forward PE | 21.10 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,070,779 |
| Open | 1.900 |
| Previous Close | 1.930 |
| Day's Range | 1.860 - 1.990 |
| 52-Week Range | 1.860 - 3.920 |
| Beta | 2.24 |
| Analysts | Buy |
| Price Target | 3.07 (+63.3%) |
| Earnings Date | May 5, 2026 |
About CLOV
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Financial Performance
In 2025, Clover Health Investments's revenue was $1.92 billion, an increase of 40.33% compared to the previous year's $1.37 billion. Losses were -$85.55 million, 98.9% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for CLOV stock is "Buy." The 12-month stock price target is $3.07, which is an increase of 63.30% from the latest price.
News
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
NOTICE: This is an updated version of a press release originally issued March 4, 2026 by Clover Health Investments, Corp. (Nasdaq: CLOV). Language has been updated to further refine the description of...
Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
WILMINGTON, Del., March 04, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing ...
Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call Transcript
Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call Transcript
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-year Achieved industry-leading 2026 AEP growth of 53%...
Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
WILMINGTON, Del., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial res...
Clover Health Is Undervalued With Clear Signs Of A 2026 Profit Breakout
Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. CLOV's member retention exceeds 90%, older cohorts generate $217 monthly profit, a...
Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Clover Health Investments, Corp. (CLOV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong ...
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
SAN FRANCISCO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Counterpart Health , Inc. (“Counterpart” or the “Company”), a leading AI-powered physician-enablement platform and subsidiary of Clover Health Investme...
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
WILMINGTON, Del., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andr...
Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Clover Health Investments, Corp. (CLOV) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits
Despite disappointing YTD earnings due to higher than expected medical costs, Clover's expected GAAP profitability in 2026 marks a critical inflection point. Clover's higher returning member mix and t...
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
WILMINGTON, Del., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...
Clover Health Investments, Corp. (CLOV) Presents at UBS Global Healthcare Conference 2025 Transcript
Clover Health Investments, Corp. ( CLOV) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Kuipers - Chief Financial Officer Presentation Unknown Analyst...
Clover Health Investments, Corp. (CLOV) Q3 2025 Earnings Call Transcript
Clover Health Investments, Corp. ( CLOV) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Ryan Schmidt - Investor Relations Analyst Andrew Toy - Co-Founder, CEO & Director Pete...
Clover Health Reports Third Quarter 2025 Results
Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greate...
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced that Chelsea Clinton, the longest-servi...
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. New whitepaper demonstrates how CA enables primary care t...
Clover Health: Clinical Excellence To Fuel SaaS Growth Beyond The Star Downgrade
Clover's latest star rating downgrade was mainly driven by low member experience scores, which is an aspect it fully controls in its business. Despite low member experience scores, members' ratings fo...
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...
Clover Health's 2026 Medicare Advantage Plans Champion Affordability and Choice
The Company Reinforces Market Position, Maintaining Comprehensive PPO Portfolio As Clover Assistant Drives Sustainable Value The Company Reinforces Market Position, Maintaining Comprehensive PPO Portf...
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans Technology platform again powers top-tier HEDIS results for Clover Health Medicare Advantage plans
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
Company underscores differentiated business model; reiterates confidence in its ability to drive above-market membership growth and increasing Adjusted EBITDA profitability1 through 2027, independent ...
Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025
WILMINGTON, Del., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company dedicated to bringing a...